These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26456952)

  • 1. The influence of lung metastases on the clinical course of gestational trophoblastic neoplasia: a historical cohort study.
    Vree M; van Trommel N; Kenter G; Sweep F; Ten Kate-Booij M; Massuger L; Lok C
    BJOG; 2016 Oct; 123(11):1839-45. PubMed ID: 26456952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung metastases in low-risk gestational trophoblastic neoplasia: a retrospective cohort study.
    Frijstein MM; Lok C; van Trommel NE; Ten Kate-Booij MJ; Massuger L; van Werkhoven E; Short D; Aguiar X; Fisher RA; Kaur B; Sarwar N; Sebire NJ; Seckl MJ
    BJOG; 2020 Feb; 127(3):389-395. PubMed ID: 31794098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors of relapse in low-risk gestational trophoblastic neoplasia patients successfully treated with methotrexate alone.
    Couder F; Massardier J; You B; Abbas F; Hajri T; Lotz JP; Schott AM; Golfier F
    Am J Obstet Gynecol; 2016 Jul; 215(1):80.e1-7. PubMed ID: 26829503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
    Lybol C; Sweep FC; Harvey R; Mitchell H; Short D; Thomas CM; Ottevanger PB; Savage PM; Massuger LF; Seckl MJ
    Gynecol Oncol; 2012 Jun; 125(3):576-9. PubMed ID: 22410329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience.
    Maestá I; Nitecki R; Horowitz NS; Goldstein DP; de Freitas Segalla Moreira M; Elias KM; Berkowitz RS
    Gynecol Oncol; 2018 Jan; 148(1):161-167. PubMed ID: 29092742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lung metastasis on the treatment and prognosis of patients with gestational trophoblastic neoplasia: A systematic review and meta-analysis.
    Zhang T; Guo Y; He X; Hou M; Wang L; An R; Gao L
    Acta Obstet Gynecol Scand; 2024 Apr; 103(4):636-644. PubMed ID: 38282348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of weekly intramuscular methotrexate in the treatment of low risk gestational trophoblastic neoplasia.
    Hasanzadeh M; Tabari A; Homae F; Shakeri M; Bakhshandeh T; MadaniSani F
    J Cancer Res Ther; 2014; 10(3):646-50. PubMed ID: 25313754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and survival of patients with FIGO high-risk gestational trophoblastic neoplasia: the U.K. experience, 1995-2010.
    Agarwal R; Alifrangis C; Everard J; Savage PM; Short D; Tidy J; Fisher RA; Sebire NJ; Harvey R; Hancock BW; Coleman RE; Seckl MJ
    J Reprod Med; 2014; 59(1-2):7-12. PubMed ID: 24597279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study.
    Lybol C; Centen DW; Thomas CM; ten Kate-Booij MJ; Verheijen RH; Sweep FC; Ottevanger PB; Massuger LF
    BJOG; 2012 Nov; 119(12):1465-72. PubMed ID: 22925191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Curative effects and influenced factors of primary chemotherapy with single-agent methotrexate on low-risk gestational trophoblastic neoplasia].
    Wu XD; Chen LL; Shen T; Chen SS; Chen QQ; Qin JL; Fu YF; Lü WG
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1769-1772. PubMed ID: 28647996
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
    Chen YX; Shen YM; Qian JH; Xie X
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia].
    Zhou Y; Feng FZ; Xiang Y; Wan XR
    Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):804-7. PubMed ID: 21211275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for second-line dactinomycin failure after methotrexate treatment for low-risk gestational trophoblastic neoplasia: a retrospective study.
    Hoeijmakers YM; Sweep F; Lok C; Ottevanger PB
    BJOG; 2020 Aug; 127(9):1139-1145. PubMed ID: 32141676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy.
    Chapman-Davis E; Hoekstra AV; Rademaker AW; Schink JC; Lurain JR
    Gynecol Oncol; 2012 Jun; 125(3):572-5. PubMed ID: 22449733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of pulmonary metastases on therapeutic response and prognosis in malignant gestational trophoblastic neoplasia patients: a retrospective cohort study.
    Jiang F; Lin JK; Xiang Y; Xu ZF; Wan XR; Feng FZ; Ren T; Yang JJ; Zhao J
    Eur J Cancer; 2022 Jan; 161():119-127. PubMed ID: 34911640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doppler-based predictive model for methotrexate resistance in low-risk gestational trophoblastic neoplasia with myometrial invasion: prospective study of 147 patients.
    Qin J; Zhang S; Poon L; Pan Z; Luo J; Yu N; Wang L; Wu X; Cheng X; Xie X; Lu Y; Lu W
    Ultrasound Obstet Gynecol; 2021 May; 57(5):829-839. PubMed ID: 32385928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide.
    Kanno T; Matsui H; Akizawa Y; Usui H; Shozu M
    J Gynecol Oncol; 2018 Nov; 29(6):e89. PubMed ID: 30207097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of lung metastasis on prognosis of previously untreated gestational trophoblastic neoplasia patients].
    Lin JJ; Jiang F; Xiang Y; Wan XR; Feng FZ; Ren T; Yang JJ; Zhao J
    Zhonghua Zhong Liu Za Zhi; 2022 Oct; 44(10):1139-1145. PubMed ID: 36319461
    [No Abstract]   [Full Text] [Related]  

  • 19. Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study.
    Mangili G; Cioffi R; Danese S; Frigerio L; Ferrandina G; Cormio G; Rabaiotti E; Scarfone G; Gadducci A; Bergamini A; Pisano C; Candiani M
    Gynecol Oncol; 2018 Dec; 151(3):449-452. PubMed ID: 30266260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of women diagnosed and treated for low-risk gestational trophoblastic neoplasia at the Queensland Trophoblast Centre (QTC).
    Verhoef L; Baartz D; Morrison S; Sanday K; Garrett AJ
    Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):458-463. PubMed ID: 28345753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.